Generic User Fee Waivers Dropped In Latest House Draft Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Provision allowing generic drug fee waivers in shortage situations was removed in new House user fee draft, but proposals for a new antibacterial approval pathway and breakthrough designation were not included.